source
- Biopharma optimism climbs after FDA commissioner Makary's exit, survey findsEndpoints Signal released its Q3 Biopharma Sentiment Index, showing the highest level of industry optimism in years, according to a survey of 569 insiders. The index’s regulatory score rose sharpl…
- U.S. judge denies effort to block Eli Lilly's weight-loss ad; GSK reports oncology drug approvalA U.S. district judge rejected a request to halt Eli Lilly's advertising campaign that Novo Nordisk alleges is deceptive in promoting its weight‑loss medicines. Novo Nordisk argued the ads could m…